Quote | Renalytix AI plc (NASDAQ:RNLX)
Last: | $0.86 |
---|---|
Change Percent: | 0.0% |
Open: | $0.91 |
Close: | $0.86 |
High: | $0.93 |
Low: | $0.79 |
Volume: | 378,561 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Renalytix AI plc (NASDAQ:RNLX)
LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for ...
2024-03-12 12:21:11 ET More on Mid-day movers & stocks. FibroGen, Inc. 2023 Q4 - Results - Earnings Call Presentation FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes Lexaria slips ...
Message Board Posts | Renalytix AI plc (NASDAQ:RNLX)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | Moeclay | investorshub | 06/26/2023 4:13:12 PM |
$RNLX short squeeze article | Moeclay | investorshub | 06/19/2023 8:13:25 PM |
$RNLX Good news recently, we should start to see this one move | Moeclay | investorshub | 06/10/2023 7:17:06 PM |
short squeeze article | Moeclay | investorshub | 06/08/2023 10:54:56 AM |
Have a look at this | wwind | investorshub | 06/08/2023 7:25:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Renalytix AI plc Company Name:
RNLX Stock Symbol:
NASDAQ Market:
LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for ...
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Asana reported quarterly losse...
Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fisc...